Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy
- 175 Downloads
Lymph node metastasis (LNM) is known to be the most important prognostic factor in cervical cancer. We analyzed the number of positive lymph nodes and other clinicopathological factors as prognostic factors for survival in node-positive patients with cervical cancer.
Node-positive cervical cancer patients (n = 108) who underwent radical hysterectomy and systematic lymphadenectomy in Hokkaido University Hospital from 1982 to 2002 were enrolled. Clinicopathological data including age, stage, histologic subtype, and the number of LNM sites were collected. The main outcome was the overall survival (OS) rate for Stage Ib–IIb patients treated with surgery and postoperative radiotherapy.
The 5-year OS rate of patients with 1 positive node was 93.3%, that for 2 nodes was 77.3%, for 3 nodes it was 33.3%, and for 4 or more it was 13.8%. The OS rate of patients with 1 or 2 LNM sites was significantly better than that for patients with more than 2 LNM sites. The OS rate of patients with adenocarcinoma (Ad) (28.6%) was significantly lower than that for patients with other histologic subtypes (squamous cell carcinoma; 66.7%, adenosquamous carcinoma; 75.0%, p = 0.0003). Multivariate analysis revealed that >2 LNM sites and Ad were independent prognostic factors for survival. The 5-year OS rate of patients with 1 or 2 LNM sites was 86.8%, a more favorable prognosis than the OS rates in other reports.
More than two LNM sites and adenocarcinoma were independent prognostic factors for node-positive patients with cervical cancer.
KeywordsCervical cancer Prognostic factor Number of pelvic lymph node metastasis sites
We thank our colleagues (Department of Gynecology, Hokkaido University Graduate School of Medicine) for their assistance with the collection and analysis data.
Conflict of interest
No author has any conflict of interest.
- 1.Kodama J, Seki N, Ojima Y et al (2006) Prognostic factors in node-positive patients with Stage IB–IIB cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy. Int J Gynaecol Obstet 93:130–135Google Scholar
- 3.Trattner M, Graf AH, Lax S et al (2001) Prognostic factors in surgically treated Stage Ib–IIb cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol 82:11–16Google Scholar
- 4.Burghardt E, Pickel H, Haas J et al (1987) Prognostic factors and operative treatment of Stages IB to IIB cervical cancer. Am J Obstet Gynecol 156:988–996Google Scholar
- 7.Inoue T, Morita K (1990) The prognostic significance of number of positive nodes in cervical carcinoma Stages IB, IIA, and IIB. Cancer 65:1923–1927Google Scholar
- 11.Ramirez PT, Slomovitz BM, Soliman PT et al (2006) Total laparoscopic radical hysterectomy and lymphadenectomy: the M.D. Anderson Cancer Center experience. Gynecol Oncol 102:252–255Google Scholar
- 22.Kim SM, Choi HS, Byun JS (2000) Overall 5-year survival rate and prognostic factors in patients with Stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer 10:305–312Google Scholar
- 23.Cheng X, Cai S, Li Z et al (2004) The prognosis of women with Stage IB1–IIB node-positive cervical carcinoma after radical surgery. World J Surg Oncol 2:47Google Scholar